Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody
Abstract Background Dysregulated production of interleukin (IL)-6 is implicated in the pathology of inflammatory bowel disease (IBD). Neutralization of IL-6 in the gut by safe probiotic bacteria may help alleviate intestinal inflammation. Here, we developed Lactococcus lactis with potent and selecti...
Sparad:
| Huvudupphov: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMC
2022-07-01
|
| Serie: | Microbial Cell Factories |
| Ämnen: | |
| Länkar: | https://doi.org/10.1186/s12934-022-01873-7 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|